Philip Morris International Inc. Declares Regular Quarterly Dividend of $1.25 Per Share
June 17 2022 - 1:48AM
Business Wire
Regulatory News:
The Board of Directors of Philip Morris International Inc.
(NYSE: PM) today declared a regular quarterly dividend of $1.25 per
common share, payable on July 15, 2022, to shareholders of record
as of July 1, 2022. The ex-dividend date is June 30, 2022. For more
details on stock, dividends and other information, see
www.pmi.com/dividend.
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is a leading international
tobacco company working to deliver a smoke-free future and evolving
its portfolio for the long term to include products outside of the
tobacco and nicotine sector. The company’s current product
portfolio primarily consists of cigarettes and smoke-free products,
including heat-not-burn, vapor and oral nicotine products, which
are sold in markets outside the U.S. Since 2008, PMI has invested
more than USD 9 billion to develop, scientifically substantiate and
commercialize innovative smoke-free products for adults who would
otherwise continue to smoke, with the goal of completely ending the
sale of cigarettes. This includes the building of world-class
scientific assessment capabilities, notably in the areas of
pre-clinical systems toxicology, clinical and behavioral research,
as well as post-market studies. The U.S. Food and Drug
Administration (FDA) has authorized the marketing of versions of
PMI’s IQOS Platform 1 devices and consumables as Modified Risk
Tobacco Products (MRTPs), finding that exposure modification orders
for these products are appropriate to promote the public health. As
of March 31, 2022, PMI's smoke-free products are available for sale
in 71 markets, and PMI estimates that approximately 12.7 million
adults around the world excluding Russia and Ukraine, have already
switched to IQOS and stopped smoking. With a strong foundation and
significant expertise in life sciences, in February 2021 PMI
announced its ambition to expand into wellness and healthcare areas
and deliver innovative products and solutions that aim to address
unmet consumer and patient needs. For more information, please
visit www.pmi.com and www.pmiscience.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220616005932/en/
Philip Morris International Investor Relations: New York:
+1 (917) 663 2233 Lausanne: +41 (0)58 242 4666
InvestorRelations@pmi.com
Media: David Fraser Lausanne: +41 (0)58 242 4500
David.Fraser@pmi.com
Philip Morris (NYSE:PM)
Historical Stock Chart
From Apr 2024 to May 2024
Philip Morris (NYSE:PM)
Historical Stock Chart
From May 2023 to May 2024